P-MAPA against visceral leishmaniaisis

Lethal infection caused by a single cell parasite, visceral leishmaniasis spreads throughout Brazilian cities.Among the compounds currently being tested against leishmaniasis, at least one was entirely developed in Brazil by the research network Farmabrasilis. The compound is P-MAPA, an acronym for protein magnesium ammonium phospholinoleate anhydride polymer. In tests conducted in Brazil and in the United States, it has proven to be effective against Listeria monocytoges bacteria, whose survival mechanism in the organism is similar to that of the protozoa of the Leishmania genera.